Why is Ajooni Biotech falling/rising?

As of 21-Aug, Ajooni Biotech Ltd's stock price is currently at Rs 5.21, reflecting a decrease of Rs 0.1 or 1.88%. The stock has underperformed its sector today by 2.34%, and it is trading close to its 52-week low, just 3.84% above Rs 5.01. Over the past week, the stock has shown a slight increase of 1.17%, but it has significantly underperformed over the longer term, with a year-to-date decline of 32.95% and a one-year return of -25.68%. Despite positive financial results in the last four quarters, including a 21.86% growth in net sales and a 65.3% increase in profits, the stock's weak long-term fundamentals, such as a low return on capital employed and poor debt servicing ability, contribute to its downward price movement.
In the broader market context, Ajooni Biotech's recent performance contrasts with the Sensex, which has gained 1.84% over the past week and 6.09% year-to-date. This underperformance against the benchmark highlights investor concerns regarding the company's long-term growth potential, especially given its average return on capital employed of 5.11% and a poor EBIT to interest ratio. The stock's attractive valuation relative to peers, indicated by a PEG ratio of 0.4, does not seem to be enough to offset the negative sentiment stemming from its historical performance and weak fundamentals.